Dexcom (DXCM) Net Margin (2010 - 2026)
Dexcom (DXCM) posted quarterly Net Margin of 19.04% for Q2 2026, up 350.0% year-over-year from 4.23% in Q2 2025, and up 13.74% quarter-over-quarter from 16.74% in Q1 2026.
Dexcom (DXCM) Net Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Net Margin for 17 consecutive years, with 19.04% the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Margin rose 350.0% year-over-year to 19.04%; the TTM figure through Jun 2026 stood at 20.12% (up 683.0% YoY), while the FY2025 annual figure was 17.94%, up 365.0% from the prior year.
- Net Margin climbed to 19.04% in Q2 2026 per DXCM's latest filing, from 16.74% in the prior quarter.
- Across five years, Net Margin topped out at 24.78% in Q4 2023 and bottomed at 6.55% in Q1 2023.
- Historically, Net Margin has averaged 14.87% across 5 years, with a median of 13.96% in 2024.
- Annual changes were most pronounced in 2023 — Net Margin surged 1351 bps — and 2024, when it slumped 1115 bps.
- Dexcom's Net Margin stood at 11.26% in 2022, then surged by 120 bps to 24.78% in 2023, then plunged by 45 bps to 13.62% in 2024, then surged by 56 bps to 21.22% in 2025, then dropped by 10 bps to 19.04% in 2026.
- Business Quant data shows DXCM's Net Margin at 19.04% in Q2 2026, 16.74% in Q1 2026, and 21.22% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 13.47% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 9.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.04% |
| Mar 31, 2026 | 16.74% |
| Dec 31, 2025 | 21.22% |
| Sep 30, 2025 | 23.47% |
| Jun 30, 2025 | 15.54% |
| Mar 31, 2025 | 10.17% |
| Dec 31, 2024 | 13.62% |
| Sep 30, 2024 | 13.54% |
| Jun 30, 2024 | 14.29% |
| Mar 31, 2024 | 15.90% |
| Dec 31, 2023 | 24.78% |
| Sep 30, 2023 | 12.38% |
| Jun 30, 2023 | 13.30% |
| Mar 31, 2023 | 6.55% |
| Dec 31, 2022 | 11.26% |
| Sep 30, 2022 | 13.15% |
| Jun 30, 2022 | 7.31% |
| Mar 31, 2022 | 15.47% |
| Dec 31, 2021 | -0.76% |
| Sep 30, 2021 | 13.43% |